VERTEX PHARMACEUTICALS INCORPORATED Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 483 USD | -0.51% |
|
+6.08% | +18.72% |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.67% | 0 M€ | 0.00% | - | |
| 7.08% | 0 M€ | 0.00% | - | |
| 5.20% | 2 M€ | -.--% | ||
| 4.81% | 7 M€ | -.--% | - | |
| 4.05% | 111 M€ | +11.42% | - | |
| 3.53% | 1 M€ | +0.84% | - | |
| 2.32% | 2 M€ | +9.08% | ||
| 2.28% | 7 M€ | +5.53% | ||
| 1.99% | 12 M€ | +15.09% | - | |
| 1.93% | 1 M€ | 0.00% | - | |
| 1.71% | 2 M€ | -25.75% | ||
| 1.63% | 21 M€ | +8.41% | - | |
| 1.61% | 252 M€ | +7.82% | ||
| 1.58% | 9 M€ | -4.31% | - | |
| 1.10% | 204 M€ | +10.54% | ||
| 1.06% | 1,060 M€ | +3.54% | ||
| 0.87% | 9 M€ | -.--% | - | |
| 0.82% | 3 M€ | +15.16% | - | |
| 0.82% | 4 M€ | -.--% | - | |
| 0.82% | 13 M€ | -.--% | - | |
| 0.81% | 26 M€ | +16.85% | - | |
| 0.73% | 20 M€ | 0.00% | - | |
| 0.69% | 5 M€ | -72.95% | - | |
| 0.68% | 3 M€ | 0.00% | - | |
| 0.51% | 749 M€ | +8.64% |
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
2024-06-11
- Goldman Sachs Global Healthcare Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
483
USD
Average target price
463.5
USD
Spread / Average Target
-4.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.72% | 125B | |
| +14.19% | 108B | |
| -4.93% | 24.21B | |
| +3.23% | 22.78B | |
| -10.44% | 17.96B | |
| -41.74% | 16.43B | |
| -13.31% | 16.37B | |
| +2.44% | 13.58B | |
| +27.89% | 11.66B | |
| +83.45% | 9.17B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated
